Bioequivalence of Gemifloxaci
Not Applicable
- Conditions
- Healthy subjects.
- Registration Number
- IRCT20210201050197N3
- Lead Sponsor
- ?Arya Pharmaceutical Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 26
Inclusion Criteria
Healthy volunteer
Age: 18-50 year
Exclusion Criteria
History of liver, kidney and cardiovascular diseases that can affect drug clearance from body
History of taking any medication in the last two weeks
Creatinine above 2
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma drug concentration. Timepoint: 20, 40 Mins, 1,1.5, 2, 3, 4, 6, 8, 10, 12, 14, 24 Hours. Method of measurement: High performance liquid chromatography (HPLC) method.
- Secondary Outcome Measures
Name Time Method